Gerresheimer AG (ETR:GXI – Get Free Report)’s stock price dropped 0.1% during trading on Tuesday . The company traded as low as €99.15 ($106.61) and last traded at €100.40 ($107.96). Approximately 70,865 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 140,925 shares. The stock had previously closed at €100.50 ($108.06).
Gerresheimer Stock Performance
The company has a debt-to-equity ratio of 76.38, a quick ratio of 0.40 and a current ratio of 0.89. The stock has a market cap of $3.47 billion, a PE ratio of 28.85, a PEG ratio of 0.82 and a beta of 0.90. The company’s 50-day moving average price is €103.68 and its two-hundred day moving average price is €95.97.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Recommended Stories
- Five stocks we like better than Gerresheimer
- Options Trading – Understanding Strike Price
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Read Stock Charts for Beginners
- Hilton Demonstrates Asset Light is Right for Investors
- Election Stocks: How Elections Affect the Stock Market
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.